Author Guidelines

All manuscript submission need to include:
- Cover letter
- Title page
- Graphical abstract
- Main manuscript
- Copyright transfer form
- Figure or Table in separate files (if any)

 

Types of Manuscript
There are 4 types of manuscripts published by the PSA journal.

1. Original Articles Articles are comprehensive accounts of significant experimental of theoretical results. The arrangement of full-length articles should accord with the following:
    1. Title
      The full title is not limited in length but should grab attention and makes the reader interested.
    2. List of Authors (This part should appear only in the title page file)
      All authors should be listed here. Order of full name and last name must be listed as it should be in the final publication. The corresponding author is indicated by a superscript*. Any edit in the name of the author before galley proof such as mistyping, change of order, add or remove name should be informed by the formal letter and signed by all the authors only before galley proof.
    3. Affiliations
      Names and addresses of the establishments where the work was done.
    4. Abstract
      The abstract should include the basic contents of the article. The abstract format is nonstructural type. It should be briefly present (not exceeding 250 words) in one paragraph.
    5. Graphical abstract
      The graphical abstract should concisely represent your research, designed to highlight the key findings or concepts. It should be clear, using simple visuals such as diagrams, graphs, or flowcharts, with minimal text. The design should be professional, high-quality, and easily understandable by a broad audience
    6. Keywords
      Keywords or short phrases suitable for indexing should be supplied (3-5 keywords). Each keyword is start with a capital letter and is divided by a semi-colon (;).
    7. Text
      The text must be divided into main sections, such as the following: 1. Introduction, 2. Materials and methods, 3. Results, 4. Discussion, 5. Acknowledgements, 6. References.
    8. Figure and Table
      Legends, tables, and footnotes should be typed on separate sheets. Footnotes, to be numbered consecutively in superscript throughout the text, should be used as little as possible. Figures should have a resolution of at least 200 dpi. File size must be less than 2 Mb and be named as Figure number.
    9. References
      See below for full details.

2. Review Articles Review articles provide a summary of topics of general interest to pharmacists and are limited to 6,000 words.

3. Short Communications Communications are preliminary reports limited to approximately 2,000 words including 1-2 table(s)/ figure(s) with not more than 15 references.

4. Letters to the Editor Readers are invited to give an opinion on a scientific or technical subject within the scope of the Journal. If an article published in the Journal is criticized, the authors of the original article will be given an opportunity to reply in the same issue.

References Format
There are different formats for periodicals, books, etc. Please follow the Vancouver referencing style. Please cite references in the text by superscripted number. At the end of the articles, list the references in the order they appear in the text.

Author: List all authors when there are 6 or fewer. When there are more than 6, list only the first six and add et al.

1. Standard Journal Article
  • less than 6
    Alamgeer, Iman S, Asif H, Saleem M. Evaluation of antihypertensive potential of Ficus carica fruit. Pharm. Biol. 2017;55(1):1047-53.
  • Author more than 6
    Trani A, Gambacorta G, Loizzo P, Cassone A, Fasciano C, Zambrini AV, et al. Comparison of HPLC-RI, LC/MS-MS and enzymatic assays for the analysis of residual lactose in lactose-free milk. Food Chem. 2017;233:385-90.
  • Corporate Author
    Committee on Obstetric Practice, the American Institute of Ultrasound in Medicine, and the Society for Maternal-Fetal Medicine. Committee Opinion No 700: Methods for Estimating the Due Date. Obstet Gynecol. 2017;129(5):e150-e154.
  • Anonymous Author
    Anonymous. Recollections of a journey through a psychotic episode: or, mental illness and creativity. Mens Sana Monogr. 2007;5(1):188-96.
2. Books and Monographs
  • Personal Author(s)
    Lawhead JB, Baker MC. Introduction to veterinary science. Clifton Park (NY): Thomson Delmar Learning; 2005. Murray PR, Rosenthal KS, Kobayashi GS, Paller MA. Medical microbiology. 4th ed. St Louis: Mosby; 2002.
  • Corporate Author
    American Veterinary Medical Association. National Board Examination Committee. North American Veterinary Licensing Examination: bulletin of information for candidates. Bismarck (ND): The Committee; 2001.
  • Editors, Compilers, Chairmans as Authors
    Buckingham L, Flaws ML, editors. Molecular diagnostics: fundamentals, methods, and clinical applications. Philadelphia: F.A. Davis Company; 2007.
  • Chapter in Book
    Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
  • Agency Publication
    Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2014
3. Electronic Publications
Australian Institute of Health and Welfare. Chronic diseases and associated risk factors [document on the Internet]. Canberra: The Institute; 2004 [updated 2005 June 23; cited 2005 Jun 30]. Available from: http://www.aihw.gov.au/cdarf/index.cfm.

4. Patents Yusuke T, Geraldine H, Akiko M, Tadanori M, Catherine S, Donald I, inventor; Harvard College, Children's Medical Center Corp, assignee. Methods and uses for ex vivo tissue culture systems. AU 017/203220 A1. 15 May 2017

5. Proceedings
Conference proceeding Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V: Proceedings of the 5th Germ Cell Tumour conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002. Conference Paper in Print Proceedings Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming: EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

6. Thesis
Millar M. Antibiotics and antibiotic resistance: what do we owe to each other? Ph.D. [dissertation]. Birmingham: University of Birmingham; 2013.

Example of the required files

Manuscript Submission

Manuscripts must be typed, double-spaced, using Times New Roman font size 12. All pages should be numbered sequentially including line numbers. To avoid the fast rejection, the manuscript must be strictly prepared in the template format. The cover letter states the highlight or novelty of their findings and the Consent to publish and Copyright transfer Form must be submitted along with the manuscript.

The corresponding author should submit their manuscripts online only at the follow hyperlink Submit online on the right and upload all of your manuscript files following the instructions given on the screen.
 
 

Declaration on the Use of Generative AI in Scientific Writing

Authors are required to disclose any use of generative AI or AI-assisted technologies in the writing process at the time of manuscript submission.

Generative AI tools may be used to improve grammar, readability, and linguistic clarity but must be employed with human oversight and critical review. Since AI-generated content may contain errors, omissions, or biased information, authors are responsible for thoroughly verifying and editing all outputs. The final content remains entirely the responsibility of the authors.

AI technologies must not be credited as authors or co-authors, as authorship entails intellectual accountability and contributions that only humans can fulfill.

If generative AI was used in preparing the manuscript text, a statement must be included under a separate section titled “Declaration of generative AI and AI-assisted technologies in the writing process”, placed before the References section. The following template should be used:

Example Statement:
During the preparation of this work, the author(s) used [NAME OF TOOL] to [SPECIFIC PURPOSE, e.g., improve the language and readability of the manuscript]. The author(s) reviewed and edited the output as necessary and accept full responsibility for the content of the final manuscript.

Use of basic editorial tools for spelling, grammar, or reference formatting does not require disclosure.

Important: Generative AI tools such as ChatGPT are not permitted for use by peer reviewers or editors during manuscript evaluation, in order to protect author confidentiality and intellectual property.